Clinical Trial Update: Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on URG101 for interstitial cystitis/bladder pain syndrome; the study was terminated but results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Pain Syndrome
• Interstitial Cystitis

Drugs mentioned

• URG101

Snippet

Sponsor: Urigen | Conditions: Interstitial Cystitis, Bladder Pain Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2026-02-03